Opus Genetics, Inc. (IRD) — Cash Flow Reinvestment Rate
Opus Genetics, Inc. (IRD) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $4.55 Million. See free cash flow generation of Opus Genetics, Inc. to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Opus Genetics, Inc. Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Opus Genetics, Inc. across 1 annual periods. For the full cash flow conversion analysis, see IRD cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Opus Genetics, Inc. (2022–2022)
Year-by-year capital reinvestment analysis for Opus Genetics, Inc.. See Opus Genetics, Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.00x | $0.00 | $14.31 Million | $0.00 | — |